Phreesia (NYSE:PHR) SVP Amy Beth Vanduyn Sells 2,202 Shares

by · The Markets Daily

Phreesia, Inc. (NYSE:PHR – Get Free Report) SVP Amy Beth Vanduyn sold 2,202 shares of the stock in a transaction dated Friday, January 16th. The shares were sold at an average price of $16.36, for a total transaction of $36,024.72. Following the completion of the transaction, the senior vice president owned 157,349 shares of the company’s stock, valued at $2,574,229.64. This represents a 1.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

  • On Thursday, January 15th, Amy Beth Vanduyn sold 687 shares of Phreesia stock. The stock was sold at an average price of $16.38, for a total transaction of $11,253.06.
  • On Thursday, January 8th, Amy Beth Vanduyn sold 2,602 shares of Phreesia stock. The stock was sold at an average price of $17.01, for a total transaction of $44,260.02.

Phreesia Price Performance

Phreesia stock traded down $0.63 during mid-day trading on Tuesday, reaching $15.76. The company had a trading volume of 888,246 shares, compared to its average volume of 1,011,187. The stock’s 50-day simple moving average is $18.24 and its 200-day simple moving average is $23.18. Phreesia, Inc. has a 1 year low of $15.41 and a 1 year high of $32.76. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The company has a market capitalization of $950.23 million, a P/E ratio of -157.59 and a beta of 0.61.

Phreesia (NYSE:PHR – Get Free Report) last released its quarterly earnings results on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.11. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The business had revenue of $120.33 million for the quarter, compared to analysts’ expectations of $119.98 million. During the same quarter in the prior year, the firm posted ($0.25) EPS. The company’s revenue was up 12.7% compared to the same quarter last year. On average, equities analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Squarepoint Ops LLC boosted its holdings in shares of Phreesia by 243.6% during the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after purchasing an additional 71,553 shares during the last quarter. Farther Finance Advisors LLC lifted its position in Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after buying an additional 3,000 shares during the period. Arcadia Investment Management Corp MI lifted its position in Phreesia by 22.3% during the second quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock worth $3,229,000 after buying an additional 20,700 shares during the period. Acadian Asset Management LLC boosted its stake in Phreesia by 61.6% in the 2nd quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock worth $10,357,000 after buying an additional 138,877 shares during the last quarter. Finally, Boston Partners grew its holdings in Phreesia by 165.1% in the 2nd quarter. Boston Partners now owns 130,060 shares of the company’s stock valued at $3,702,000 after buying an additional 81,006 shares during the period. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

PHR has been the topic of a number of research reports. Royal Bank Of Canada started coverage on shares of Phreesia in a research note on Friday, January 9th. They issued a “moderate buy” rating and a $26.00 price objective on the stock. JPMorgan Chase & Co. lowered their price target on shares of Phreesia from $32.00 to $29.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 9th. Wells Fargo & Company initiated coverage on Phreesia in a research report on Thursday, January 8th. They set an “overweight” rating and a $30.00 price objective for the company. Mizuho lowered their target price on Phreesia from $36.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, December 10th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Phreesia in a report on Friday, October 31st. Seventeen investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.06.

Read Our Latest Research Report on Phreesia

Phreesia Company Profile

(Get Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Featured Articles